Goelzer Investment Management Inc. Has $3.88 Million Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Goelzer Investment Management Inc. decreased its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 1.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,754 shares of the medical research company’s stock after selling 198 shares during the period. Goelzer Investment Management Inc.’s holdings in IQVIA were worth $3,882,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of IQV. Exchange Traded Concepts LLC raised its position in IQVIA by 18.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 5,209 shares of the medical research company’s stock valued at $1,024,000 after purchasing an additional 821 shares during the last quarter. Brighton Jones LLC raised its holdings in shares of IQVIA by 244.4% in the fourth quarter. Brighton Jones LLC now owns 3,575 shares of the medical research company’s stock valued at $703,000 after buying an additional 2,537 shares during the last quarter. Mutual Advisors LLC lifted its position in IQVIA by 14.8% during the 4th quarter. Mutual Advisors LLC now owns 1,689 shares of the medical research company’s stock worth $334,000 after buying an additional 218 shares in the last quarter. Janney Montgomery Scott LLC grew its holdings in IQVIA by 3.3% during the 4th quarter. Janney Montgomery Scott LLC now owns 36,512 shares of the medical research company’s stock worth $7,175,000 after acquiring an additional 1,172 shares during the last quarter. Finally, Advisory Alpha LLC increased its position in IQVIA by 18.2% in the 4th quarter. Advisory Alpha LLC now owns 3,189 shares of the medical research company’s stock valued at $627,000 after acquiring an additional 492 shares in the last quarter. Institutional investors own 89.62% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on IQV. JPMorgan Chase & Co. reduced their target price on shares of IQVIA from $279.00 to $240.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft reduced their price objective on IQVIA from $270.00 to $265.00 and set a “buy” rating on the stock in a report on Friday, November 1st. The Goldman Sachs Group lowered their target price on IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Redburn Atlantic began coverage on IQVIA in a research note on Monday, October 14th. They set a “buy” rating and a $276.00 price target on the stock. Finally, Leerink Partners reiterated an “outperform” rating and issued a $248.00 price objective (down from $260.00) on shares of IQVIA in a research report on Tuesday, November 19th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $255.71.

IQVIA Price Performance

IQV opened at $204.54 on Friday. The company has a fifty day simple moving average of $199.47 and a 200 day simple moving average of $221.09. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76. The stock has a market cap of $37.12 billion, a P/E ratio of 26.84, a P/E/G ratio of 2.14 and a beta of 1.48. IQVIA Holdings Inc. has a 12 month low of $187.62 and a 12 month high of $261.73.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.